Literature DB >> 31465848

Lassa fever in pregnancy with a positive maternal and fetal outcome: A case report.

Joseph Agboeze1, Matthew Igwe Nwali2, Ebenezer Nwakpakpa2, Onwe Emeka Ogah2, Robinson Onoh2, Justus Eze2, Chukwuemeka Ukaegbe2, Nnennaya Ajayi2, Uzodimma Ugochukwu Nnadozie2, Maria-Lauretta Orji2, Kingsley Chiedozie Ojide2, Sunday Uche Unigwe2, Nneka Chika-Igwenyi2, Demian Ugonna Nwidi2, Chukwunenye Ugochukwu Clement3, Charles Kalombo3, Catherine Makwe3, Jacques Tshiang3.   

Abstract

BACKGROUND: The signs and symptoms of Lassa fever are initially indistinguishable from other febrile illnesses common in the tropics and complications of pregnancy. Surviving Lassa fever during pregnancy is rare. Only few cases have been documented. The antiviral drug of choice is ribavirin. CASE DESCRIPTION: A 25-year-old multigravida farmer with fever who was initially thought to have malaria in pregnancy at 29 weeks gestation. Further changes in her clinical state and laboratory tests led to a confirmation of Lassa fever. The Liver enzymes were markedly deranged and the packed cell volume was 27%. She commenced on ribavirin and subsequently was delivered of a live male neonate who was RT PCR negative for Lassa fever virus. Her clinical state improved, repeat RT PCR on day 15 was negative and she made full recovery. DISCUSSION: The case reported had similar clinical features of fever and abdominal pain and resulted in the initial diagnoses of Malaria in pregnancy. When she failed to respond to antimalarial and antibiotics treatments, a strong suspicion of viral hemorrhagic fever was made. At this time the patient was in advanced stage of the disease with bleeding from vagina and puncture sites. On the third day of admission she was delivered of a live male neonate who remained negative after 2 consecutive RT PCR tests for Lassa fever virus. Lassa fever carries a high risk of death to the fetus throughout pregnancy and to the mother in the third trimester. Mothers with Lassa fever improved rapidly after evacuation of the uterus by spontaneous abortion, or normal delivery. She was clinically stable following delivery. Her laboratory investigations were essentially normal. Throughout her management transmission based precautions were observed. None of the six close contacts developed symptoms after been followed up for 21 days.
CONCLUSION: This report adds to the body of literature that individuals can survive Lassa fever during pregnancy with good maternal and fetal outcome.
Copyright © 2019 The Authors. Published by Elsevier Ltd.. All rights reserved.

Entities:  

Keywords:  Abakaliki; Lassa fever; Pregnancy

Mesh:

Substances:

Year:  2019        PMID: 31465848     DOI: 10.1016/j.ijid.2019.08.023

Source DB:  PubMed          Journal:  Int J Infect Dis        ISSN: 1201-9712            Impact factor:   3.623


  7 in total

1.  Lassa fever in pregnancy: a systematic review and meta-analysis.

Authors:  Nzelle D Kayem; Charlotte Benson; Christina Y L Aye; Sarah Barker; Mariana Tome; Stephen Kennedy; Proochista Ariana; Peter Horby
Journal:  Trans R Soc Trop Med Hyg       Date:  2020-05-07       Impact factor: 2.184

2.  Clinical characterization of Lassa fever: A systematic review of clinical reports and research to inform clinical trial design.

Authors:  Laura Merson; Josephine Bourner; Sulaiman Jalloh; Astrid Erber; Alex Paddy Salam; Antoine Flahault; Piero L Olliaro
Journal:  PLoS Negl Trop Dis       Date:  2021-09-21

3.  Case Report: COVID-19 and Lassa Fever Coinfection in an Ebola Suspected Patient in Guinea.

Authors:  Mory Keita; Mahamoud Sama Cherif; Billy Sivahera; Samuel T Boland; Freddy Banza-Mutoka; Mamadou Kourouma; Alseny Modet Camara; Youssouf Sidibe; Jean Paul Kimenyi; Lamine Diassy; Angelo Loua; Ibrahima Sory Fofana; Youba Kandako; Dobo Onivogui; Enogo Koivogui; Tamba Jacques Millimono; Fode Diakite; Mamadou Balde; Bienvenu Houndjo; Ngoy Nsenga; Ambrose Talisuna; Alexandre Delamou; Olivia Keiser; Georges Alfred Ki-Zerbo; Abdou Salam Gueye
Journal:  Am J Trop Med Hyg       Date:  2022-02-25       Impact factor: 2.345

Review 4.  Pathogenicity and virulence mechanisms of Lassa virus and its animal modeling, diagnostic, prophylactic, and therapeutic developments.

Authors:  Hannah L Murphy; Hinh Ly
Journal:  Virulence       Date:  2021-12       Impact factor: 5.882

5.  Public health response to two imported, epidemiologically related cases of Lassa fever in the Netherlands (ex Sierra Leone), November 2019.

Authors:  Femke Overbosch; Mark de Boer; Karin Ellen Veldkamp; Pauline Ellerbroek; Chantal P Bleeker-Rovers; Bram Goorhuis; Michele van Vugt; Annemiek van der Eijk; Tjalling Leenstra; Martin Khargi; Jeanette Ros; Diederik Brandwagt; Manon Haverkate; Corien Swaan; Chantal Reusken; Aura Timen; Marion Koopmans; Jaap van Dissel
Journal:  Euro Surveill       Date:  2020-04

Review 6.  Recent Updates on Research Models and Tools to Study Virus-Host Interactions at the Placenta.

Authors:  Jae Kyung Lee; Soo-Jin Oh; Hosun Park; Ok Sarah Shin
Journal:  Viruses       Date:  2019-12-18       Impact factor: 5.048

7.  Fatal case of newborn Lassa fever virus infection mimicking late onset neonatal sepsis: a case report from northern Nigeria.

Authors:  Taofik Oluwaseun Ogunkunle; Surajudeen Oyeleke Bello; Chinwe Immaculata Anderson; Rashida Musa; Rasaq Olaosebikan; Abdulazeez Imam
Journal:  Infect Dis Poverty       Date:  2020-08-10       Impact factor: 4.520

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.